HbA1c, diabetes and cognitive decline: the English Longitudinal Study of Ageing
Open accessThe DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
The aim of the study was to evaluate longitudinal associations between HbA 1c levels, diabetes status and subsequent cognitive decline over a 10 year follow-up period. Data from wave 2 (2004–2005) to wave 7 (2014–2015) of the English Longitudinal Study of Ageing (ELSA) were analysed. Cognitive function was assessed at baseline (wave 2) and reassessed every 2 years at waves 3–7. Linear mixed models were used to evaluate longitudinal associations. The study comprised 5189 participants (55.1% women, mean age 65.6 ± 9.4 years) with baseline HbA 1c levels ranging from 15.9 to 126.3 mmol/mol (3.6–13.7%). The mean follow-up duration was 8.1 ± 2.8 years and the mean number of cognitive assessments was 4.9 ± 1.5. A 1 mmol/mol increment in HbA 1c was significantly associated with an increased rate of decline in global cognitive z scores (−0.0009 SD/year, 95% CI −0.0014, −0.0003), memory z scores (−0.0005 SD/year, 95% CI −0.0009, −0.0001) and executive function z scores (−0.0008 SD/year, 95% CI −0.0013, −0.0004) after adjustment for baseline age, sex, total cholesterol, HDL-cholesterol, triacylglycerol, high-sensitivity C-reactive protein, BMI, education, marital status, depressive symptoms, current smoking, alcohol consumption, hypertension, CHD, stroke, chronic lung disease and cancer. Compared with participants with normoglycaemia, the multivariable-adjusted rate of global cognitive decline associated with prediabetes and diabetes was increased by −0.012 SD/year (95% CI −0.022, −0.002) and −0.031 SD/year (95% CI −0.046, −0.015), respectively ( p for trend <0.001). Similarly, memory, executive function and orientation z scores showed an increased rate of cognitive decline with diabetes. Significant longitudinal associations between HbA 1c levels, diabetes status and long-term cognitive decline were observed in this study. Future studies are required to determine the effects of maintaining optimal glucose control on the rate of cognitive decline in people with diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These tests have been shown to have high validity and reliability in the studies of others [16–18].”
From Digital exclusion and cognitive impairment in older people: findings from five longitudinal studies (2024) · cites this paper as [16]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Toprak, O., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney and Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,627
Diagnosis and Classification of Diabetes Mellitus
American Diabetes Association (2011) · Diabetes Care · doi:10.2337/dc11-s062 · Cited by 13,988
Diagnosis and classification of diabetes mellitus
American Diabetes Association (2014) · Diabetes Care · doi:10.2337/dc14-s081 · Cited by 5,974
Diagnosis and classification of diabetes mellitus
American Diabetes Association (2010) · Diabetes Care · doi:10.2337/dc10-s062 · Cited by 5,491
Prediabetes: a high-risk state for diabetes development
Tabák, A. G., Herder, C., Rathmann, W., Brunner, E. J., & Kivimäki, M. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60283-9 · Cited by 2,958 · cited 1×
“4%] [14]) and/or diabetes are associated with accelerated cognitive decline in an elderly population with normal cognition at baseline; and (2) to examine whether people with diabetes with better glycaemic control, as measured by HbA1c levels, show a similar or decreased rate of subsequent cognitive decline.”
BackgroundThe projected effect of risk factor reduction on Alzheimer's disease prevalence
Barnes, D. E., & Yaffe, K. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70072-2 · Cited by 2,666
Monnier, L., Mas, E., Ginet, C., Michel, F., Villon, L., Cristol, J.-P., & Colette, C. (2006) · JAMA · doi:10.1001/jama.295.14.1681 · Cited by 2,444
Risk of dementia in diabetes mellitus: a systematic review
Biessels, G. J., Staekenborg, S., Brunner, E., Brayne, C., & Scheltens, P. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(05)70284-2 · Cited by 2,187
Cohort profile: The English longitudinal study of ageing
Steptoe, A., Breeze, E., Banks, J., & Nazroo, J. (2013) · International Journal of Epidemiology · doi:10.1093/ije/dys168 · Cited by 1,779
Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults
Selvin, E., Steffes, M. W., Zhu, H., Matsushita, K., Wagenknecht, L., Pankow, J., Coresh, J., & Brancati, F. L. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0908359 · Cited by 1,544
Research works printed but not linked: 1
- Graig R Deverill C Pickering K Spronston K Mindell J Quality control of blood saliva and urine analytes Health Survey for England 2004: methodology and documentation 2006 London The Information Centre
Cited by
Xue, M., Xu, W., Ou, Y.-N., Cao, X.-P., Tan, M.-S., Tan, L., & Yu, J.-T. (2019) · Ageing Research Reviews · doi:10.1016/j.arr.2019.100944 · Cited by 715
Association between sleep duration and cognitive decline
Ma, Y., Liang, L., Zheng, F., Shi, L., Zhong, B., & Xie, W. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.13573 · Cited by 535
Self-citationCognitive Decline Before and After Incident Coronary Events
Xie, W., Zheng, F., Yan, L., & Zhong, B. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.04.019 · Cited by 279
Self-citationThe Impact of Disease Comorbidities in Alzheimer’s Disease
Santiago, J. A., & Potashkin, J. A. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.631770 · Cited by 259
“For example, HbAc1, a measure of average blood glucose level, has been positively associated with the increased risk of cognitive decline and dementia in several studies (Yaffe et al., 2006; Rawlings et al., 2017; Zheng et al., 2018).”
BackgroundAssociation of Cumulative Blood Pressure With Cognitive Decline, Dementia, and Mortality
Li, C., Zhu, Y., Ma, Y., Hua, R., Zhong, B., & Xie, W. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2022.01.045 · Cited by 233
Self-citationChanging demography and the challenge of dementia in India
Ravindranath, V., & Sundarakumar, J. S. (2021) · Nature Reviews Neurology · doi:10.1038/s41582-021-00565-x · Cited by 172
Ray, J., Popli, G., & Fell, G. (2018) · JAMA Otolaryngology–Head & Neck Surgery · doi:10.1001/jamaoto.2018.1656 · Cited by 163
Luo, A., Xie, Z., Wang, Y., Wang, X., Li, S., Yan, J., Zhan, G., Zhou, Z., Zhao, Y., & Li, S. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104642 · Cited by 162
Adaptation of the Gut Microbiota to Modern Dietary Sugars and Sweeteners
Rienzi, S. C. D., & Britton, R. A. (2019) · Advances in Nutrition · doi:10.1093/advances/nmz118 · Cited by 148
Progression of cognitive decline before and after incident stroke
Zheng, F., Yan, L., Zhong, B., Yang, Z., & Xie, W. (2019) · Neurology · doi:10.1212/wnl.0000000000007716 · Cited by 147
“To allow direct comparisons among cognitive tasks, we calculated z scores standardized to wave 1 for each test by subtracting the mean score at wave 1 from the participant’s test score at each wave and dividing by the SD of the wave 1 scores.(17) Then, we calculated a composite global cognitive z score by averaging th…”
MethodSelf-citationCognitive dysfunction: a growing link between diabetes and Alzheimer’s disease
Jash, K., Gondaliya, P., Kirave, P., Kulkarni, B., Sunkaria, A., & Kalia, K. (2020) · Drug Development Research · doi:10.1002/ddr.21579 · Cited by 119
Mui, J. V., Zhou, J., Lee, S., Leung, K. S. K., Lee, T. T. L., Chou, O. H. I., Tsang, S. L., Wai, A. K. C., Liu, T., Wong, W. T., et al. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.747620 · Cited by 113
Zhu, Y., Li, C., Xie, W., Zhong, B., Wu, Y., & Blumenthal, J. A. (2022) · Age and Ageing · doi:10.1093/ageing/afab191 · Cited by 112
Self-citationVadini, F., Simeone, P. G., Boccatonda, A., Guagnano, M. T., Liani, R., Tripaldi, R., Di Castelnuovo, A., Cipollone, F., Consoli, A., & Santilli, F. (2020) · International Journal of Obesity · doi:10.1038/s41366-020-0535-5 · Cited by 110
“The Verbal Fluency Test assesses verbal ability and executive control, and was previously used as a measure of executive function [1].”
BackgroundMethodPersistent depressive symptoms and cognitive decline in older adults
Zheng, F., Zhong, B., Song, X., & Xie, W. (2018) · The British Journal of Psychiatry · doi:10.1192/bjp.2018.155 · Cited by 106
Self-citationVascular cognitive impairment and dementia in type 2 diabetes mellitus: An overview
Lyu, F., Wu, D., Wei, C., & Wu, A. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117771 · Cited by 109
Vascular dementia: From pathobiology to emerging perspectives
Morgan, A. E., & Auley, M. T. M. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102278 · Cited by 116
“Moreover, a 1 mmol/mol increase in HbA1c has been associated with a greater rate of decline in global memory and executive functioning z scores (Zheng et al., 2018).”
BackgroundAmyloid-β and Phosphorylated Tau are the Key Biomarkers and Predictors of Alzheimer’s Disease
Pradeepkiran, J. A., Baig, J., Islam, M. A., Kshirsagar, S., & Reddy, P. H. (2024) · Aging and Disease · doi:10.14336/ad.2024.0286 · Cited by 102
The Effects of Dietary Advanced Glycation End-Products on Neurocognitive and Mental Disorders
D'Cunha, N. M., Sergi, D., Lane, M. M., Naumovski, N., Gamage, E., Rajendran, A., Kouvari, M., Gauci, S., Dissanayaka, T. D., Marx, W., et al. (2022) · Nutrients · doi:10.3390/nu14122421 · Cited by 88
“Furthermore, higher HbA1c levels were associated with both diabetes and long-term cognitive decline in the English Longitudinal Study of Ageing (n = 5189) [121].”
BackgroundAssociation Between the Use of Antihyperglycemic Drugs and Dementia Risk: A Case-Control Study
Bohlken, J., Jacob, L., & Kostev, K. (2018) · Journal of Alzheimer's Disease · doi:10.3233/jad-180808 · Cited by 67
Fan, Z., Lv, X., Tu, L., Zhang, M., Yu, X., & Wang, H. (2021) · Social Science & Medicine · doi:10.1016/j.socscimed.2021.114423 · Cited by 82
Insulin resistance, cognition, and Alzheimer disease
Kim, A. B., & Arvanitakis, Z. (2023) · Obesity · doi:10.1002/oby.23761 · Cited by 75
Different hypertension thresholds and cognitive decline: a pooled analysis of three ageing cohorts
Ma, Y., Hua, R., Yang, Z., Zhong, B., Yan, L., & Xie, W. (2021) · BMC Medicine · doi:10.1186/s12916-021-02165-4 · Cited by 64
Self-citationTeixeira, M. M., Passos, V. M. D. A., Barreto, S. M., Schmidt, M. I., Duncan, B. B., Beleigoli, A. M. R., Fonseca, M. J. M., Vidigal, P. G., Araújo, L. F., & Diniz, M. D. F. H. S. (2020) · Scientific Reports · doi:10.1038/s41598-020-58332-9 · Cited by 68
Diabetes: a tipping point in neurodegenerative diseases
Santiago, J. A., Karthikeyan, M., Lackey, M., Villavicencio, D., & Potashkin, J. A. (2023) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2023.09.005 · Cited by 72
Cadar, D., Abell, J. G., Matthews, F. E., Brayne, C., Batty, G. D., Llewellyn, D. J., & Steptoe, A. (2020) · International Journal of Epidemiology · doi:10.1093/ije/dyaa227 · Cited by 70
Mechanistic insights and emerging therapeutic stratagems for Alzheimer’s disease
Rajendran, K., & Krishnan, U. M. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102309 · Cited by 63
Digital exclusion and cognitive impairment in older people: findings from five longitudinal studies
Wang, Y., Wu, Z., Duan, L., Liu, S., Chen, R., Sun, T., Wang, J., Zhou, J., Wang, H., & Huang, P. (2024) · BMC Geriatrics · doi:10.1186/s12877-024-05026-w · Cited by 55
John, C. M., Yusof, N. I. S. M., Aziz, S. H. A., & Fauzi, F. M. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19123894 · Cited by 54
Glucose Fluctuations Are Linked to Disrupted Brain Functional Architecture and Cognitive Impairment
Xia, W., Luo, Y., Chen, Y., Chen, H., Ma, J., & Yin, X. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-191217 · Cited by 52
“A recent longitudinal study suggested that the management of blood glucose was significantly associated with the rate of decline in global cognition as well as in memory and executive function [5].”
Sugar ecologies: their metabolic and racial effects
Hatch, A. R., Sternlieb, S. R., & Gordon, J. T. (2019) · Food Culture & Society · doi:10.1080/15528014.2019.1638123 · Cited by 52
“A host of physical and cognitive health problems has been linked to excess sugar consumption, including obesity, type 2 diabetes, heart disease, and Alzheimer’s disease (Zheng et al. 2018; Stanhope 2016; Basu et al. 2013).”
BackgroundGlycogen synthase kinase-3 as a key regulator of cognitive function
Fan, X., Zhao, Z., Wang, D., & Xiao, J. (2020) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmz156 · Cited by 55
Dose-Response Relationship Between Long-Term Blood Pressure Variability and Cognitive Decline
Li, C., Ma, Y., Hua, R., Yang, Z., Zhong, B., Wang, H., & Xie, W. (2021) · Stroke · doi:10.1161/strokeaha.120.033697 · Cited by 50
Self-citationHay, M., Barnes, C. A., Huentelman, M. J., Brinton, R. D., & Ryan, L. (2020) · Current Hypertension Reports · doi:10.1007/s11906-020-01090-w · Cited by 55
Persistent moderate to severe pain and long‐term cognitive decline
Wei, R., Zhang, C., Zheng, F., Xiao, S., Yang, Z., & Xie, W. (2021) · European Journal of Pain · doi:10.1002/ejp.1826 · Cited by 52
“Cognitive assessment included three aspects: temporal orientation, semantic fluency and verbal memory (Zheng & Xie, 2018; Zheng et al., 2018).”
MethodSelf-citationKim, W. J., Lee, S. J., Lee, E., Lee, E. Y., & Han, K. (2022) · Diabetes Care · doi:10.2337/dc21-0957 · Cited by 45
Huo, M., Wang, Z., Fu, W., Lu, T., Li, W., Zhou, Z., Chen, Y., Wei, J., & Abliz, Z. (2021) · Journal of Proteome Research · doi:10.1021/acs.jproteome.1c00179 · Cited by 46
Liang, J., Li, C., Gao, D., Ma, Q., Wang, Y., Pan, Y., Zhang, W., Xie, W., & Zheng, F. (2023) · Journal of the American Heart Association · doi:10.1161/jaha.123.031407 · Cited by 46
“First, CHD and dementia share many risk factors, 5,6,28,29 which could induce atherosclerosis, resulting in cerebral hypoperfusion and hypoxia.”
Self-citationQuiñones, A. R., Kaye, J. A., Allore, H. G., Botoseneanu, A., & Thielke, S. M. (2020) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317520960874 · Cited by 48
Ding, L., Zhu, X., Xiong, Z., Yang, F., & Zhang, X. (2022) · Journal of General Internal Medicine · doi:10.1007/s11606-022-07951-1 · Cited by 45
Li, C., Ma, Y., Hua, R., Zheng, F., & Xie, W. (2022) · Age and Ageing · doi:10.1093/ageing/afac071 · Cited by 48
Self-citationOnset age of diabetes and incident dementia: A prospective cohort study
Wang, Y., Li, C., Liang, J., Gao, D., Pan, Y., Zhang, W., Zhang, Y., Zheng, F., & Xie, W. (2023) · Journal of Affective Disorders · doi:10.1016/j.jad.2023.02.138 · Cited by 36
Self-citationExecutive Function and Diabetes: A Clinical Neuropsychology Perspective
Zhao, Q., Zhang, Y., Liao, X., & Wang, W. (2020) · Frontiers in Psychology · doi:10.3389/fpsyg.2020.02112 · Cited by 43
“Studies conducted in different countries among various ethnic groups have also reached similar conclusions [e.g., Spain (Mallorqui-Bague et al., 2018), Netherlands (Geijselaers et al., 2017), United Kingdom (Zheng et al., 2018), and Poland (Luczynski et al., 2019)].”
BackgroundResultInfluentialKirvalidze, M., Hodkinson, A., Storman, D., Fairchild, T. J., Bała, M. M., Beridze, G., Zuriaga, A., Brudasca, N. I., & Brini, S. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104551 · Cited by 43
Zhang, H., Fan, F., Zhong, B., & Chiu, H. F. K. (2023) · General Psychiatry · doi:10.1136/gpsych-2023-101054 · Cited by 38
Self-citationHashimoto, M., Matsuzaki, K., Hossain, S., Ito, T., Wakatsuki, H., Tanabe, Y., Ohno, M., Kato, S., Yamashita, K., & Shido, O. (2021) · Foods · doi:10.3390/foods10051130 · Cited by 35
“Serum BAP levels were positively correlated (p = 0.032) with FAB scores at baseline after adjustment for serum albumin, blood sugar, and HbA1c (Figure 5).”
BackgroundInfluentialType-2-Diabetes Alters CSF but Not Plasma Metabolomic and AD Risk Profiles in Vervet Monkeys
Kavanagh, K., Day, S. M., Pait, M. C., Mortiz, W. R., Newgard, C. B., Ilkayeva, O., McClain, D. A., & Macauley, S. L. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00843 · Cited by 32
Risk factors for mild cognitive impairment in type 2 diabetes: a systematic review and meta-analysis
Zhao, Y., Wang, H., Tang, G., Wang, L., Tian, X., & Li, R. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1617248 · Cited by 46
“Zheng et al. (103) reported that each 1 mmol/mol increase in HbA1c exacerbates declines in cognitive, memory, and executive functions.”
Predictors of cognitive impairment in treatment-resistant depression
Gregory, E., Torres, I. J., Ge, R., Blumberger, D. M., Downar, J. H., Daskalakis, Z. J., Lam, R. W. M., & Vila‐Rodriguez, F. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.05.101 · Cited by 31
Dietary sugar intake and risk of Alzheimer's disease in older women
Liu, L., Volpe, S. L., Ross, J. A., Grimm, J. A., Bockstaele, E. J. V., & Eisen, H. J. (2021) · Nutritional Neuroscience · doi:10.1080/1028415x.2021.1959099 · Cited by 40
Mimenza-Alvarado, A. J., Jiménez-Castillo, G. A., Yeverino-Castro, S. G., Barragán-Berlanga, A. J., Pérez‐Zepeda, M. U., Ávila‐Funes, J. A., & Aguilar-Navarro, S. G. (2020) · BMC Geriatrics · doi:10.1186/s12877-020-01827-x · Cited by 35
Xiao, Y., Hong, X., Neelagar, R., & Mo, H. (2025) · Scientific Reports · doi:10.1038/s41598-025-89374-6 · Cited by 28
Diabetes and Prediabetes Inhibit Reversion from Mild Cognitive Impairment to Normal Cognition
Makino, K., Lee, S., Bae, S., Chiba, I., Harada, K., Katayama, O., Shinkai, Y., Makizako, H., & Shimada, H. (2021) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2021.02.033 · Cited by 34
Trajectories of Cognition and Daily Functioning Before and After Incident Diabetes
Ji, X., Gao, H., Sun, D., Zhuang, J., Fang, Y., Wang, K., & Ahmadizar, F. (2022) · Diabetes Care · doi:10.2337/dc22-1190 · Cited by 29
Qiao, H., Meng, C., Li, S., Li, Y., Sun, Y., & Wu, Y. (2020) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2020.104129 · Cited by 28
Wang, K., Zhao, S., Lee, E. K. P., Yau, S. Z.-M., Wu, Y., Hung, C.-T., & Yeoh, E. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.55733 · Cited by 38
Jin, C.-Y., Yu, S., Yin, J.-T., Yuan, X.-Y., & Wang, X. (2022) · Heliyon · doi:10.1016/j.heliyon.2022.e10073 · Cited by 28
Carbohydrates in nutrition: friend or foe?
Großkopf, A., & Simm, A. (2020) · Zeitschrift für Gerontologie und Geriatrie · doi:10.1007/s00391-020-01726-1 · Cited by 33
Mechanisms underlying cognitive impairment and management strategies in type 2 diabetes
Chen, X., Huang, Y., & Xiong, X. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1655768 · Cited by 39
“Chronically elevated blood glucose is a key factor linking T2D to MCI, dementia, and AD (27).”
Dyer, A. H., Briggs, R., Mockler, D., Gibney, J., & Kennelly, S. (2019) · QJM · doi:10.1093/qjmed/hcz053 · Cited by 34
Veronese, N., Noale, M., Sinclair, A. J., Barbagallo, M., Dominguez, L. J., Smith, L., Pizzol, D., & Maggi, S. (2021) · Age and Ageing · doi:10.1093/ageing/afab222 · Cited by 28
Kwan, R. Y. C., Kwan, C. W., Kor, P. P. K., & Chi, I. (2022) · BMC Geriatrics · doi:10.1186/s12877-022-02895-x · Cited by 28
Hu, X., Meier, M., & Pruessner, J. C. (2023) · Brain and Behavior · doi:10.1002/brb3.2925 · Cited by 24
“…al., 2007; Barnes & Yaffe, 2011), not drinking alcohol excessively (Koch et al., 2019), keeping a healthy weight (Horie et al., 2016), healthy diet (Knight et al., 2016; Shannon et al., 2019), normotension (deHeus et al., 2019; Qiu et al., 2005), and normal blood sugar levels (Zheng et al., 2018).”
BackgroundMartínez, C. G., Babió, N., Júlvez, J., Becerra‐Tomás, N., Martínez‐González, M. Á., Corella, D., Castañer, O., Romaguera, D., Vioqué, J., Alonso‐Gómez, Á. M., et al. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.754347 · Cited by 27
Pappas, C. A., Small, B. J., Andel, R., Laczó, J., Pařízková, M., Lerch, O., & Hort, J. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180693 · Cited by 28
“Elevated glucose levels have been associated with poorer memory [10, 11] and a greater rate of decline in executive function and memory abilities [12].”
Zhu, Y., Li, C., Wu, T., Wang, Y., Hua, R., Ma, Y., & Xie, W. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.09.128 · Cited by 27
Self-citationPatil, R. S., & Tupe, R. S. (2023) · Medicinal Research Reviews · doi:10.1002/med.21987 · Cited by 26
Liu, S., Lu, Y., Cai, X., Cong, R., Li, J., Jiang, H., & Li, M. (2019) · Current Alzheimer Research · doi:10.2174/1567205016666191023110712 · Cited by 25
Prefrontal cortex brain damage and glycemic control in patients with type 2 diabetes
CHOI, S. E., Roy, B., Freeby, M., MULLUR, R. S., Woo, M. A., & Kumar, R. (2019) · Journal of Diabetes · doi:10.1111/1753-0407.13019 · Cited by 23
Zhao, L., Han, C., Zheng, Z., Xiu, S., & Chan, P. (2020) · BMC Endocrine Disorders · doi:10.1186/s12902-020-00606-4 · Cited by 25
Glycemic traits and Alzheimer’s disease: a mendelian randomization study
Pan, Y., Chen, W., Yan, H., Wang, M., & Xiang, X. (2020) · Aging · doi:10.18632/aging.103887 · Cited by 44
“In the English Longitudinal Study of Ageing study with 5189 participants and 10-year follow-up, HbA1c levels and diabetes status were associated with long-term cognitive decline [4].”
BackgroundPossible cognition changes in women with polycystic ovary syndrome: a narrative review
Naz, M. S. G., Rahnemaei, F. A., Tehrani, F. R., Sayehmiri, F., Ghasemi, V., Banaei, M., & Ozgoli, G. (2023) · Obstetrics & Gynecology Science · doi:10.5468/ogs.22165 · Cited by 28
“…and 40 healthy female aimed at examining cognitive dysfunction showed that visual-spatial ability was lower in female with PCOS relative to healthy female and that decreasing visual-spatial cognition was related to hemoglobin A1c levels [74], which are associated with cognitive function [75,76].”
BackgroundWood, D., Evangelopoulos, D., Beevers, S. D., Kitwiroon, N., Demakakos, P., & Katsouyanni, K. (2024) · Environmental Health · doi:10.1186/s12940-024-01075-1 · Cited by 24
“Tests of word recall and the animal naming test have been shown to display good construct validity both in ELSA and other cohorts [29, 44].”
Age at Onset of Heart Failure and Subsequent Risk of Dementia
Zheng, F., Liang, J., Li, C., Ma, Q., Pan, Y., Zhang, W., Gao, D., Wang, Y., & Xie, W. (2023) · JACC Heart Failure · doi:10.1016/j.jchf.2023.08.006 · Cited by 29
Self-citationQiao, H., Du, X., Li, S., Sun, Y., Feng, W., & Wu, Y. (2021) · Psychiatry Research · doi:10.1016/j.psychres.2021.113807 · Cited by 28
Cukierman‐Yaffe, T., McClure, L. A., Risoli, T. J., Bosch, J., Sharma, M., Gerstein, H. C., & Benavente, O. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab022 · Cited by 21
Liu, C., Meng, Q., Zu, C., Wei, Y., Su, X., Zhang, Y., He, P., Zhou, C., Liu, M., Ye, Z., et al. (2023) · Clinical Nutrition · doi:10.1016/j.clnu.2023.06.021 · Cited by 18
Wu, J., Zhang, L., Liu, D., Xia, J., Yang, Y., Tang, F., Chen, L., Ao, H., & Peng, C. Y. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.116955 · Cited by 22
Little, M. O. (2018) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2018.07.001 · Cited by 23
Higher dementia incidence in older adults with type 2 diabetes and large reduction in HbA1c
Lee, A. T. C., Richards, M., Chan, W. C., Chiu, H. F. K., Lee, R. S. Y., & LAM, L. C. W. (2019) · Age and Ageing · doi:10.1093/ageing/afz108 · Cited by 22
Sotomayor, E. M., Onetti-Onetti, W., Castillo-Rodríguez, A., & González-Jurado, J. A. (2020) · Sustainability · doi:10.3390/su12125038 · Cited by 21
“It has been demonstrated that DM is a pathology that enhances cognitive deterioration in older people [18,20].”
BackgroundLi, C., Ma, Y., Hua, R., Zheng, F., & Xie, W. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.769549 · Cited by 20
Self-citationLu, Y., Zhu, Y., Ma, Y., Li, C., Hua, R., Zhong, B., Wang, H., & Xie, W. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-059024 · Cited by 18
Self-citationMalkowski, O. S., Kanabar, R., & Western, M. J. (2023) · Scientific Reports · doi:10.1038/s41598-023-33371-0 · Cited by 21
“Cognitive function was assessed via a time orientation test (i.e., reporting the correct day of week, day of month, month, and year), instant and delayed recall of ten common words, and a verbal fluency task requiring participants to name as many animals as possible in 60 s 24,30 .”
Cichosz, S. L., Jensen, M. H., & Hejlesen, O. K. (2019) · Primary care diabetes · doi:10.1016/j.pcd.2019.11.005 · Cited by 21
Shi, S., Kou, W., Bian, Z., Chen, X., Song, L., Fu, L., & Qiu, P. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.09.049 · Cited by 19
Lehoczki, A., Csípő, T., Lipécz, Á., Major, D., Fazekas‐Pongor, V., Csík, B., Mózes, N., Fehér, Á., Dósa, N., Árva, D., et al. (2025) · Nutrients · doi:10.3390/nu17152446 · Cited by 24
“Overall, the research findings indicate that the higher an individual’s blood sugar level, the faster the rate of cognitive decline [402,403].”
Chai, S., Liu, F., Yu, S., Yang, Z., & Sun, F. (2023) · Journal of Diabetes Investigation · doi:10.1111/jdi.14015 · Cited by 19
Self-citationSikalidis, A. K., Kelleher, A., Maykish, A., & Kristo, A. S. (2020) · Medicina · doi:10.3390/medicina56100490 · Cited by 22
Glucose-lowering drugs, cognition, and dementia: The clinical evidence
Wu, C., Shapiro, L. R., Ouk, M., MacIntosh, B. J., Black, S. E., Shah, B. R., & Swardfager, W. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104654 · Cited by 24
Shapiro, A. L. B., Dabelea, D., Stafford, J. M., D’Agostino, R., Jr., Pihoker, C., Liese, A. D., SHAH, A. S., Bellatorre, A., Lawrence, J. M., Henkin, L. F., et al. (2021) · Diabetes Care · doi:10.2337/dc20-2308 · Cited by 20
Hua, R., Xiong, J., Li, G., Zhu, Y., Ge, Z., Ma, Y., Fu, M., Li, C., Wang, B., Dong, L., et al. (2022) · Age and Ageing · doi:10.1093/ageing/afac282 · Cited by 17
Self-citationLi, T., Hu, W., Han, Q., Wang, Y., Ma, Z., Chu, J., He, Q., Feng, Z., Sun, N., & Shen, Y. (2023) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2023.105219 · Cited by 18
Zhang, M., Liu, T., Li, C., Wang, J., & Wu, D. (2018) · Journal of Advanced Nursing · doi:10.1111/jan.13901 · Cited by 15
Shen, J., Yu, H., Li, K., Ding, B., Xiao, R., & Ma, W. (2022) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s353449 · Cited by 19
Yu, J. S., Lee, K., Kim, H., Han, K., & Lee, S.-H. (2023) · Scientific Reports · doi:10.1038/s41598-023-47566-y · Cited by 17
Joint Models for Estimating Determinants of Cognitive Decline in the Presence of Survival Bias
Davis-Plourde, K. L., Mayeda, E. R., Lodi, S., Filshtein, T., Beiser, A., Gross, A. L., Seshadri, S., Glymour, M. M., & Tripodis, Y. (2022) · Epidemiology · doi:10.1097/ede.0000000000001472 · Cited by 15
Tang, X., Wang, Y., Simó, R., Stehouwer, C. D. A., & Zhou, J. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-220972 · Cited by 15
“…andmetformin)[79,80],diabeticcomplications (includingdiabeticretinopathy[81–83]anddiabetic nephropathy[84,85]),long-timeglucosefluctuation [79, 86], and the duration of CKD and CVD, may confound the association between diabetes duration and cognitive…”
Hobson, P., Lewis, A., Nair, H., Wong, S. P. Y., & Kumwenda, M. J. (2018) · BMJ Open · doi:10.1136/bmjopen-2018-023520 · Cited by 18
Chanti‐Ketterl, M., Stebbins, R. C., Obhi, H. K., Belsky, D. W., Plassman, B. L., & Yang, Y. C. (2021) · The Journals of Gerontology Series A · doi:10.1093/gerona/glab285 · Cited by 17
Metadata
- Authors
- Zheng, F., Yan, L., Yang, Z., Zhong, B., & Xie, W.
- Affiliations
- Chinese Academy of Sciences (CN)
- Imperial College London (GB)
- Peking University (CN)
- Corresponding author
- Xie, Wuxiang
- Venue
- Diabetologia
- Published
- 2018-01-25
- Volume
- 61
- Issue
- 4
- Pages
- 839-848
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- PMC
- PMC6448974
- OpenAlex
- W2791177277
- Cited by
- 280
- References
- 32
- Citations by year
- 2026: 31 · 2025: 54 · 2024: 35 · 2023: 35 · 2022: 30 · 2021: 34 · 2020: 24 · 2019: 24 · 2018: 13
- FWCI
- 18.69
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- Locations
- Diabetologia (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Spiral (Imperial College London) (submittedVersion, cc-by)
- Funders
- Academy of Medical Sciences (P56804)
- National Natural Science Foundation of China (81601176)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
- Health Sciences › Medicine › Oncology › Cancer-related cognitive impairment studies
- Keywords
- HbA1c, diabetes mellitus, prediabetes, cognitive decline, memory, executive function, older adults, English Longitudinal Study of Ageing, glycemic control, dementia risk, HbA1c thresholds, cognitive function trajectories, HbA1c trajectories, diabetes subtypes
- MeSH terms
- Aged, Blood Glucose, Cognition, Cross-Sectional Studies, Diabetes Mellitus, England, Female, Follow-Up Studies, Glycated Hemoglobin, Humans, Longitudinal Studies, Male, Memory, Middle Aged, Reproducibility of Results, Treatment Outcome, Diabetes Complications, Executive Function, Cognitive Dysfunction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.